“Canada now faces a crucial choice. It can ignore or fight these technological advances by shutting the door to healthcare innovation and concluding that what we do now is “good enough.” The other option is to embrace the dramatic changes in science and healthcare and harness them for the…
Opinion
Today, women make up 50% of university students enrolled in STEM and health programs in Canada.[1] Women identifying as visible minorities make up 44.4% of women aged 25 years or older with a post-secondary degree or higher in STEM.[2] However, these numbers do not translate equally into the workforce where…
While life sciences is a crucial pillar of our economy, and holds the key to Canada’s response, recovery, and resilience efforts in the context of the current and future pandemics, there is widespread consensus that the sector is not achieving its full potential. We need a more attractive commercial environment for…
Dr. Jason Field’s separates facts from fiction in a constructive www.healthydebate.ca article (https://healthydebate.ca/opinions/failed-drug-pricing-policy/). When other countries were working collaboratively with the life sciences sector as soon as #COVID hit, Health Canada was imposing drastic and uncertain price controls. Myths are separated from facts on key issues, including How much Canadians actually spend…
The federal government recently announced the shortlist for its $950 million innovation superclusters initiative, with a notable omission: Out of nine proposals, not one is dedicated to health and life sciences — government’s single biggest budgetary challenge, our largest economic growth opportunity, and a priority for most Canadians. The only…
To grow our economy, government’s concept of what it means to invest in knowledge industries must change, says LSO President and CEO Jason Field The Trudeau government, Toronto Star columnist Paul Wells noted, came out of the gate hell-bent on consulting us. And consult us they did. The Liberal’s election in…
Jason Field, Life Sciences Ontario President & CEO, on the dangerous myths putting Canada’s pharmaceutical industry at risk US President Donald Trump recently sent biotech stocks tumbling with his claim that the pharmaceutical industry is “getting away with murder.” In a meeting with major US pharma companies this week, he again…
It’s been a long and bumpy road toward CETA. The much-anticipated Comprehensive Economic and Trade Agreement between Canada and the European Union was signed by Prime Minister Justin Trudeau on Sunday under provisional terms, bringing the majority of the deal into force. The agreement continues provisions directly impacting Canada’s life…
The federal government recently launched consultations to develop a Canada-wide innovation agenda. Each year, there are dozens of conferences, symposia, and surveys consulting our knowledge industries. The government wants to know how to translate our strengths in science and technology into jobs and economic prosperity. Time and time again, the…
Insights from Dr. Jason Field, President & CEO, Life Sciences OntarioMore than 60 of Canada’s hottest life sciences companies presented to a keen audience of US and international investors at the Bloom Burton conference last week in Toronto. There is no question in my mind that Canada is at a…